Fangjun Chen
Yantai University(CN)China-Japan Friendship Hospital(CN)Nanjing Drum Tower Hospital(CN)Weifang University(CN)
Publications by Year
Research Areas
Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Cancer-related molecular mechanisms research, Immune Cell Function and Interaction, CAR-T cell therapy research
Most-Cited Works
- → CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients(2016)302 cited
- → Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors(2019)224 cited
- → iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer(2019)123 cited
- → Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis(2014)109 cited
- → CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer(2016)97 cited
- → Upregulation of the Long Non-coding RNA PlncRNA-1 Promotes Esophageal Squamous Carcinoma Cell Proliferation and Correlates with Advanced Clinical Stage(2013)94 cited